First Bancshares, Inc. Announces Third Quarter 2016 Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
First Bancshares, Inc. Announces Third Quarter 2016 Results

MOUNTAIN GROVE, Mo., Oct. 21, 2016 (GLOBE NEWSWIRE) -- First Bancshares, Inc. (“Company”), (OTCQB:FBSI), the holding company for First Home Bank (“Bank”), today announced its financial results for the quarter ended September 30, 2016.

For the quarter ended September 30, 2016, the Company had net income of $171,000, or $0.11 per share – diluted, compared to net income of $86,000, or $0.06 per share – diluted for the quarter ended September 30, 2015.  The $85,000 increase in net income for the quarter ended September 30, 2016 compared to the quarter ended September 30, 2015 is attributable to an increase of $107,000 in net interest income and a $7,000 increase in gain on sale of investments.  This was partially offset by a $9,000 decrease in non-interest income and a $20,000 increase in non-interest expenses.

“We are pleased with our continued progress.  The solid increase in quarterly net income compared to the same quarter last year provides support for our fundamental operating plan to increase loan asset volume while maintaining very high asset quality,” said R. Bradley Weaver, Chairman, President and Chief Executive Officer of the Company. “We are very proud of the improvements we have made and continue to make.  Through the commitment of our employees to our principles of sound banking practices, we continue to improve our earnings and balance sheet,” Weaver concluded.

During the quarter ended September 30, 2016, net interest income increased by $107,000, or 7.64%, to $1.51 million from $1.40 million during the same quarter in 2015.  This increase in net interest income was the result of an increase in interest income of $137,000, or 8.15% and was partially offset by an increase of $30,000, or 10.68%, in interest expense.  The increase in interest income is due to the growth in the Company’s loan portfolio.  The increase in interest expense was primarily the result of an increase in the Company’s deposit portfolio.

There was no provision for loan losses for the quarters ended September 30, 2016 and September 30, 2015.  Classified loans at September 30, 2016 were $696,000 compared to $1.54 million at September 30, 2015.  The allowance for loan losses at September 30, 2016 was $1.69 million, or 1.26% of total loans, compared to $1.70 million, or 1.439% of total loans at September 30, 2015.

For the quarter ended September 30, 2016, the Company had a gain on sale of investments of $7,000.  During the quarter ended September 30, 2015, the Company did not sell any investments. The $7,000 gain realized during the current quarter represents Agency securities that were called at par during the quarter that the Company had purchased at a discount.

Non-interest income decreased by $9,000, or 3.61% to $240,000 for the quarter ended September 30, 2016 from $249,000 for the same quarter in 2015.  The decrease was the result of a decrease in gains on sale of OREO of $10,000.  This was partially offset by an increase of $1,000 in other non-interest income items.

Non-interest expense increased by $20,000, or 1.35%, to $1.50 million for the quarter ended September 30, 2016 from $1.48 million for the quarter ended September 30, 2015.  The increase in non-interest expense reflects an increase of $41,000 in salaries and employee benefits, an increase of $13,000 in data processing fees and an increase of $9,000 in other non-interest expense items.  These increases were partially offset by a $43,000 decrease in professional fees consisting of legal, accounting and consulting service related expenses.

For the nine months ended September 30, 2016, the Company had net income of $491,000, or $0.32 per share – diluted, compared to net income of $2.72 million, or $1.76 per share – diluted for the nine months ended September 30, 2015.  The $2.23 million decrease in net income for the nine months ended September 30, 2016 compared to the nine months ended September 30, 2015 is attributable to an increase of $129,000 in non-interest expenses and a $251,000 tax expense for the nine months ended September 30, 2016 versus an income tax benefit of $2.30 million for the nine months ended September 30, 2015.  This was partially offset by an increase of $322,000 in net interest income, a decrease of $60,000 in provision for loan losses, an increase of $25,000 in gain on sale of investments and a $43,000 increase in non-interest income.

There was no provision for loan losses for the nine months ended September 30, 2016 compared to a $60,000 provision expense during the same period in 2015.  The decrease in the provision for loan losses during the nine months ended September 30, 2016 is attributable to our commitment to high quality assets in our loan portfolio.

During the nine months ended September 30, 2016, the Company had a gain on sale of investments of $14,000 compared to a loss on sale of investments of $11,000 during the same period in 2015.

Non-interest income increased by $43,000, or 6.23%, to $733,000 for the nine months ended September 30, 2016, compared to $690,000 for the same period in 2015.  The increase in non-interest income reflects an increase of $34,000 in service charges on deposit accounts and a $9,000 increase in other non-interest income items.

Non-interest expense increased by $129,000, or 2.95%, to $4.51 million for the nine months ended September 30, 2016, compared to $4.38 million for the nine months ended September 30, 2015.  The increase is attributable to an increase in salaries and employee benefits of $112,000, a $42,000 increase in losses and expenses on debit cards, an increase of $48,000 in data processing fees and an increase of $34,000 in debit card expenses related to converting to EMV chip cards.  This was partially offset by a decrease of $18,000 in premises and fixed assets, a decrease of $85,000 in professional fees consisting of legal, accounting and consulting service related expenses and a $4,000 decrease in other non-interest expenses.

Total consolidated assets at September 30, 2016 were $220.42 million, compared to $213.03 million at December 31, 2015, representing an increase of $7.39 million, or 3.47%.  Stockholders’ equity at September 30, 2016 was $20.07 million, or 9.10% of assets, compared with $18.55 million, or 8.71% of assets at December 31, 2015.  Book value per common share increased to $12.96 at September 30, 2016 from $11.98 at December 31, 2015.  The $1.52 million, or 8.17% increase in stockholders’ equity was attributable to an increase in the unrealized gains on available-for-sale securities, net of income taxes of $1.03 million and by net income of $491,000 million for the nine months ended September 30, 2016.

Net loans receivable increased $8.04 million, or 6.45%, to $132.56 million at September 30, 2016 from $124.53 million at December 31, 2015.  Loan growth continues to be the primary focus to improve earnings.  This focus is tempered with the company’s continuous attention to high quality underwriting and strong asset quality management.  The goal is to increase the size of the loan portfolio without any sacrifice to quality.  Nonperforming loans at September 30, 2016 were $86,000, or 0.06% of net loans, compared to $697,000 in nonperforming loans, or 0.56% of net loans at December 31, 2015.  Deposits increased $6.66 million, or 3.77% to $183.37 million at September 30, 2016 from $176.71 million at December 31, 2015.  FHLB advances decreased $3.0 million or 23.08%, to $10.00 million at September 30, 2016 from $13.0 million at December 31, 2015.

First Bancshares, Inc. is the holding company for First Home Bank, a FDIC-insured commercial bank chartered by the State of Missouri that conducts business from its home office in Mountain Grove, Missouri, and seven full service offices in Marshfield, Ava, Gainesville, Sparta, Springfield, Crane, and Kissee Mills, Missouri.

The Company and its wholly-owned subsidiary, First Home Bank, may from time to time make written or oral “forward-looking statements” in its reports to shareholders, and in other communications by the Company, which are made in good faith by the Company pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995.

These forward-looking statements include statements with respect to the Company’s beliefs, expectations, estimates and intentions that are subject to significant risks and uncertainties, and are subject to change based on various factors, some of which are beyond the Company’s control. Such statements address the following subjects: future operating results; customer growth and retention; loan and other product demand; earnings growth and expectations; new products and services; credit quality and adequacy of reserves; results of examinations by our bank regulators, technology, and our employees. The following factors, among others, could cause the Company’s financial performance to differ materially from the expectations, estimates and intentions expressed in such forward-looking statements: the strength of the United States economy in general and the strength of the local economies in which the Company conducts operations; the effects of, and changes in, trade, monetary, and fiscal policies and laws, including interest rate policies of the Federal Reserve Board; inflation, interest rate, market, and monetary fluctuations; the timely development and acceptance of new products and services of the Company and the perceived overall value of these products and services by users; the impact of changes in financial services’ laws and regulations; technological changes; acquisitions; changes in consumer spending and savings habits; and the success of the Company at managing and collecting assets of borrowers in default and managing the risks of the foregoing.

The foregoing list of factors is not exclusive. The Company does not undertake, and expressly disclaims any intent or obligation, to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company.

First Bancshares, Inc. and Subsidiaries
Financial Highlights
(In thousands, except per share amounts)
         
         
  Quarter Ended Nine Months Ended
  September 30, September 30,
   2016   2015   2016   2015 
Operating Data:        
         
Total interest income $1,819  $1,682  $5,412  $5,004 
Total interest expense  311   281   909   823 
Net interest income  1,508   1,401   4,503   4,181 
Provision for loan losses  -   -   -   60 
Net interest income after provision for loan losses  1,508   1,401   4,503   4,121 
Gain (loss) on sale of investments  7   -   14   (11)
Non-interest income  240   249   733   690 
Non-interest expense  1,497   1,477   4,508   4,379 
Income before taxes  258   173   742   421 
Income tax expense (benefit)  87   87   251   (2,303)
Net income $171  $86  $491  $2,724 
         
Earnings per share $0.11  $0.06  $0.32  $1.76 
         
  At At    
  September 30, December 31,    
Financial Condition Data:  2016   2015     
         
Cash and cash equivalents $7,076  $9,573     
(excludes CDs)      
Investment securities  7,541   64,835     
(includes CDs)      
Loans receivable, net  132,562   124,527     
Total assets  220,423   213,030     
Deposits  183,370   176,713     
Repurchase agreements  6,281   4,127     
FHLB advances  10,000   13,000     
Stockholders' equity  20,065   18,550     
Book value per share $12.96  $11.98     

Contact:  R. Bradley Weaver Chairman, President and CEO (417) 926-5151

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 245

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 477

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 20

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 42

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 317

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 214

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 572

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

Old National Bancorp Declares Dividends to Benefit Shareholders

Updated Category News Views 180

Old National Bancorp Declares Cash Dividends Old National Bancorp, the holding company of Old National Bank, has recently made an important announcement regarding its quarterly dividends. The Board of Directors has officially declared a cash dividend of $0.14 per share on the Company’s outstanding shares of common stock. This move underlines the company’s commitment...

Continue Reading
Revolutionary Portable Target Board Streamlines Axe Throwing Fun

Updated Category News Views 295

Innovative Design for Axe Throwing Enthusiasts A new invention is transforming the world of axe throwing. A creative inventor sought to develop a robust solution for supporting heavy wooden targets. With this ambition in mind, he has introduced the AXXMAN BOARD, which enhances the experience of axe throwing while also ensuring safety and stability. This product aims to...

Continue Reading
AI Innovations Transforming Automotive Lighting Market Growth

Updated Category News Views 158

AI Innovations Transforming Automotive Lighting Market Growth The global automotive lighting market is poised for remarkable growth, with an expected increase of approximately USD 12.38 billion between 2024 and 2028. This growth is largely driven by the rising demand for advanced interior lighting systems, particularly in passenger and commercial vehicles. The advent of...

Continue Reading
Wolverine World Wide Insider Purchase Signals Optimism

Updated Category News Views 148

Wolverine World Wide Insider Purchase Signals Optimism In a recent filing, it has come to light that DeMonty Price, a board member of Wolverine World Wide (NYSE:WWW), made a significant insider purchase, affirming confidence in the future of the company. Details of the Transaction On a recent date, Price purchased 25,000 shares of Wolverine World Wide. This strategic move...

Continue Reading
Saigon Technology's Impact on Vietnam's Global Innovation Scene

Updated Category News Views 205

Saigon Technology's Impact on Vietnam's Global Innovation Scene Saigon Technology is making waves in the tech world, showcasing Vietnam's potential as a vibrant hub for global innovation. This remarkable company has recently achieved significant milestones that solidify its position in the industry. With its unyielding commitment to excellence, Saigon Technology has...

Continue Reading